This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: John Douglas Davis: Innovator in Pharmaceutical Formulations
Introduction
John Douglas Davis is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release formulations. His work is essential for improving the efficacy of medications used in treating various conditions.
Latest Patents
Davis holds a patent for a pharmaceutical formulation that provides a controlled-release mechanism for oral administration. This formulation includes 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline, or a pharmaceutically acceptable salt thereof. The invention is characterized by its ability to release at least 50% by weight of the active ingredient after 6 hours under specific testing conditions. This formulation is particularly suitable for the treatment of Benign Prostatic Hyperplasia (BPH).
Career Highlights
Davis is associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on innovative solutions that enhance patient care through effective drug delivery systems. His patent reflects his commitment to advancing pharmaceutical science.
Collaborations
Davis has collaborated with notable colleagues, including Michael John Humphrey and Ross James Macrae. These partnerships have contributed to the development of innovative pharmaceutical solutions.
Conclusion
John Douglas Davis is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to controlled-release formulations. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.